Hydrocortisone Inhibits Cellular Proliferation by Downregulating Hepatocyte Growth Factor Synthesis in Human Osteoblasts

  • Tsunashima Yoshihiko
    Department of Pharmacology, School of Dentistry, Aichi-Gakuin University
  • Kondo Ayami
    Department of Pharmacology, School of Dentistry, Aichi-Gakuin University
  • Matsuda Tomohiro
    Department of Pharmacology, School of Dentistry, Aichi-Gakuin University
  • Togari Akifumi
    Department of Pharmacology, School of Dentistry, Aichi-Gakuin University

この論文をさがす

抄録

Glucocorticoids have multiple systemic effects that may influence bone metabolism but also directly affect osteoblasts by decreasing their proliferation. Using human osteoblastic SaM-1 cells, we examined whether the effects of hydrocortisone on cellular proliferation are mediated by hepatocyte growth factor (HGF). Human osteoblasts constitutively express both HGF and c-Met, its receptor. Hydrocortisone decreased the gene and protein expression of HGF as well as proliferation in SaM-1 cells. These hydrocortisone (0.01—1 μM)-induced decreases in HGF synthesis and cellular proliferation occurred in a concentration-dependent manner. However, no hydrocortisone (0.01—1 μM)-induced decrease in cellular proliferation was observed in human osteosarcoma-derived cells (HOS and SaOS-2), which are not able to produce HGF. In the cellular proliferation in SaM-1 cells, the decrease was blocked concentration-dependently by exogenously applied HGF (0.01—3 ng/ml). Furthermore, SU11274 (1 μM), a highly specific inhibitor of c-Met, suppressed the proliferation of SaM-1 cells, but not HOS cells. From these results, we concluded that hydrocortisone inhibits the proliferation of SaM-1 cells by interrupting the autocrine/paracrine loop via the downregulation of HGF synthesis.

収録刊行物

参考文献 (24)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ